Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore a comprehensive grand rounds presentation examining the transition to precision medicine in cardiology through the lens of biomarkers and risk assessment. Learn how to evaluate cardiovascular risk assessment approaches using biomarkers like c-reactive protein, troponins, and natriuretic peptides, while understanding their strengths and limitations. Master the application of actuarial risk assessment for specific cardiovascular outcomes to guide prevention and treatment decisions. Discover strategies for incorporating risk assessment into population health initiatives for cardiovascular prevention, presented by Dr. James de Lemos, Chief of Cardiology at UT Southwestern, as he discusses whether biomarkers can truly add precision to cardiovascular medicine, prevention, and population health.
